Hedge Fund Stock Picks & Ticker Coverage
Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Cedar Grove Capital Management Paul Cerro | “Evolv Technologies ($EVLV) provides AI-powered weapons-detection screening gateways for high-traffic environments, including schools, stadiums, and hospitals. Unlike conventional walkthrough metal detectors that require slow manual bag checks and pat-downs, Evolv uses advanced sensors and machine vision to screen patrons quickly and unobtrusively. The manager is highly bullish on the company as their largest position, arguing that the market has mistakenly penalized the stock due to past regulatory inquiries and rising interest rates, even as fundamental execution remains stellar. Financially, Evolv operates an attractive recurring revenue model centered on 48-month non-cancelable subscription contracts. Customers lease or purchase the screening hardware and pay an ongoing annual software fee, creating a razor/razor-blade unit economic engine with net revenue retention over 100%. The business demonstrates significant operating leverage as subscription software scales, with remaining performance obligations reaching $312.6 million. Despite accelerating revenue growth and expanding adjusted EBITDA margins, EVLV's valuation multiple has compressed from 8x to approximately 4.1x enterprise value to forward sales. Key growth catalysts include continued cross-selling into the eXpedite bag-screening system, enterprise contract renewals, and potential acquisition interest given private equity activity in the sector. Downside risks involve regulatory compliance scrutiny regarding marketing claims, lingering skepticism over historical accounting adjustments, and macro-driven multiple compression in small-cap technology.” | BULL | Q3 2026 Oct 5, 2026 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.